Literature DB >> 26120163

Uncommon Presentation of a Common Histiocytic Tumor: A Rare Entity.

Chinmay Kar1, Kapildev Das1, Jayanta K Barua1.   

Abstract

Juvenile xanthogranuloma (JXG) is the most common form of non-Langerhans cell histiocytic lesion, characterized by benign, usually asymptomatic, self-healing yellowish brown papulonodular lesions of skin and other organs in the absence of metabolic disorder. The cells of origin of JXG are dermal dendrocytic cells. Histopathologically there is dermal infiltration of foamy or non-foamy histiocytes with or without giant cell. Immunohistochemistry shows CD68 positivity with CD1a and S-100 negativity of lesional cells although S-100-positive JXG have been reported. JXG may be associated with neurofibromatosis type one (NF 1) with increased risk of juvenile chronic myelogenous leukemia and other hematological malignancies. Our case was S-100 immunoreactive multiple, cutaneous JXGs with NF 1 without any visceral involvement or malignant complication. We are presenting this case due to its rarity.

Entities:  

Keywords:  Juvenile xanthogranuloma; S-100 protein; neurofibromatosis type one

Year:  2015        PMID: 26120163      PMCID: PMC4458948          DOI: 10.4103/0019-5154.156395

Source DB:  PubMed          Journal:  Indian J Dermatol        ISSN: 0019-5154            Impact factor:   1.494


  5 in total

1.  Juvenile xanthogranuloma in childhood and adolescence: a clinicopathologic study of 129 patients from the kiel pediatric tumor registry.

Authors:  Dirk Janssen; Dieter Harms
Journal:  Am J Surg Pathol       Date:  2005-01       Impact factor: 6.394

2.  A case of S-100-positive juvenile xanthogranuloma: a longitudinal observation.

Authors:  Yosuke Yamamoto; Masafumi Kadota; Youichi Nishimura
Journal:  Pediatr Dermatol       Date:  2009 Jul-Aug       Impact factor: 1.588

3.  Juvenile xanthogranulomas in the first two decades of life: a clinicopathologic study of 174 cases with cutaneous and extracutaneous manifestations.

Authors:  Louis P Dehner
Journal:  Am J Surg Pathol       Date:  2003-05       Impact factor: 6.394

4.  [Disseminated juvenile xanthogranuloma expressing protein S100].

Authors:  M Amouri; N Gouiaa; H Chaaben; A Masmoudi; A Zahaf; T Boudawara; H Turki
Journal:  Ann Dermatol Venereol       Date:  2011-12-06       Impact factor: 0.777

5.  Juvenile xanthogranuloma in a child with previously unsuspected neurofibromatosis type 1 and juvenile myelomonocytic leukemia.

Authors:  Margarita Raygada; Diane C Arthur; Alan S Wayne; Owen M Rennert; Jeffrey A Toretsky; Constantine A Stratakis
Journal:  Pediatr Blood Cancer       Date:  2010-01       Impact factor: 3.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.